Literature DB >> 12489791

Diabetes modulates the expression of glomerular kinin receptors.

Julie Christopher1, Ayad A Jaffa.   

Abstract

The localization of kinin receptors within the kidney implicates this system in the regulation of glomerular hemodynamics. We reported that diabetes alters the activity of the renal kallikrein-kinin system, and that these alterations contribute to the development of microvascular complications of diabetes. The present study examined the influence of diabetes on the expression of glomerular B1 and B2-kinin receptors, and assessed the cellular signaling of kinin receptor activation. Rats made diabetic with streptozocin (85 mg/kg), displayed plasma glucose levels in the range of 350-500 mg/dl. At 3, 7, and 21 days, B1 and B2-kinin receptor mRNA levels were measured in isolated glomeruli from control and diabetic rats by RT-PCR. Glomeruli revealed a differential pattern of expression between the two kinin receptors. The constitutively expressed B2-receptor was increased three-fold at day 3, but returned to normal levels at day 7; whereas, the inducible B1-receptor was maximally expressed (20-fold) at day 7 and remained elevated (10-fold) at day 21. To test whether the induction of kinin receptors by diabetes translates into increased responsiveness, we measured mitogen-activated protein kinase (MAPK) phosphorylation (p42, p44) in glomeruli isolated from control and diabetic rats stimulated with B1-receptor agonist (des-Arg9-bradykinin, 10(-8) M). A three-fold increase in phosphorylation of MAPK was observed in response to B1-receptor agonist challenge in glomeruli isolated form diabetic rats compared to controls. These findings demonstrate for the first time that glomerular kinin receptors are induced by diabetes, and provide a rationale to study the contribution of these receptors to the development of glomerular injury in diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489791     DOI: 10.1016/s1567-5769(02)00188-1

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells.

Authors:  Sinisa Stanisavljevic; Tatjana Ignjatovic; Peter A Deddish; Viktor Brovkovych; Kai Zhang; Ervin G Erdös; Randal A Skidgel
Journal:  J Pharmacol Exp Ther       Date:  2005-11-10       Impact factor: 4.030

2.  Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.

Authors:  J Abou Msallem; H Chalhoub; M Al-Hariri; L Saad; M A Jaffa; F N Ziyadeh; A A Jaffa
Journal:  Am J Physiol Renal Physiol       Date:  2015-10-07

3.  Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes.

Authors:  Miran A Jaffa; Firas Kobeissy; Moustafa Al Hariri; Hussein Chalhoub; Assaad Eid; Fuad N Ziyadeh; Ayad A Jaffa
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 4.  The kallikrein-kinin system in diabetic nephropathy.

Authors:  Hirofumi Tomita; Ryan B Sanford; Oliver Smithies; Masao Kakoki
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

5.  Balance between the two kinin receptors in the progression of experimental focal and segmental glomerulosclerosis in mice.

Authors:  Rafael Luiz Pereira; Raphael José Ferreira Felizardo; Marcos Antônio Cenedeze; Meire Ioshie Hiyane; Enio José Bassi; Mariane Tami Amano; Clarice Sylvia Taemi Origassa; Reinaldo Correia Silva; Cristhiane Fávero Aguiar; Sylvia Mendes Carneiro; João Bosco Pesquero; Ronaldo Carvalho Araújo; Alexandre de Castro Keller; Renato C Monteiro; Ivan Cruz Moura; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Dis Model Mech       Date:  2014-04-17       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.